Bausch + Lomb Corporation (BLCO.TO) TSX
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CAD
Address
520 Applewood Crescent
Vaughan, ON L4K 4B4
Canada
Phone
905 695 7700
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
13500
First IPO Date
May 06, 2022
| Name | Title | Pay | Year Born |
| Brenton L. Saunders | Chief Executive Officer & Chairman | 7.96M | 1970 |
| Andrew Stewart | President of Global Pharmaceuticals & International Consumer | 1.77M | 1976 |
| Yehia Hashad | Executive Vice President of Research & Development and Chief Medical officer | 2.04M | 1968 |
| A. Robert D. Bailey | Executive Vice President & Chief Legal Officer | 2.08M | 1963 |
| Osama A. Eldessouky | Executive Vice President & Chief Financial Officer | 2.53M | 1972 |
| Frederick J. Munsch | Senior Vice President, Controller & Chief Accounting Officer | 0 | 1970 |
| Alan Waterhouse CPFA | Executive Vice President and Chief Supply Chain & Operations Officer | 0 | 1960 |
| Jonathon L. Kellerman | Chief Compliance Officer | 0 | N/A |
| Crawford | Chief Communications Officer | 0 | N/A |
| George Gadkowski | Vice President & Head of Investor Relations & Business Insights | 0 | N/A |
Bausch + Lomb Corporation is a global leader in eye health, delivering a wide range of products and services across the world. Its business is divided into three key areas: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care sector offers an extensive selection of contact lenses, covering options from daily disposables to frequently replaced types, in addition to lens care solutions, non-prescription eye drops, and vitamin and mineral supplements designed to alleviate conditions such as eye allergies, conjunctivitis, and dry eye. Within the Ophthalmic Pharmaceuticals division, the company develops and markets both proprietary and generic medications for post-operative recovery and the management of ophthalmic conditions like glaucoma, ocular hypertension, and retinal diseases, alongside therapeutic contact lenses. Finally, the Surgical segment equips medical professionals with advanced tools and technologies for cataract, vitreous, and retinal treatments, including intraocular lenses with their specialized delivery systems, phacoemulsification apparatus, and other essential surgical instruments. Founded in 1853, Bausch + Lomb's headquarters are situated in Vaughan, Canada.